Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis

Nature Reviews Rheumatology

Volumn 7, Issue 6, 2011, Pages 340-348

  Beaulieu, Elaine ^a   Morand, Eric F ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; GLUCOCORTICOID; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LEUCINE ZIPPER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FKHRL1; TSC22 DOMAIN FAMILY PROTEIN 3; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ACNE; ADAPTIVE IMMUNITY; ADIPOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTHRITIS; AVASCULAR NECROSIS; CATARACT; CD4+ T LYMPHOCYTE; CELL SURVIVAL; COLITIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; DENDRITIC CELL; DIABETES MELLITUS; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNOREGULATION; IMPAIRED GLUCOSE TOLERANCE; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MENTAL INSTABILITY; MYOPATHY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN ATROPHY; SODIUM RETENTION; SYNOVIOCYTE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VASCULAR FRAGILITY;

ARTHRITIS, RHEUMATOID; GLUCOCORTICOIDS; HUMANS; IMMUNOMODULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 79958118789     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.59     Document Type: Review

References (67)

1. Chrousos, G. P. The hypothalamic-pituitary- adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332, 1351-1362 (1995).
2. Slocumb, C. H., Polley, H. F., Hench, P. S. & Kendall, E. C. Effects of cortisone and ACTH on patients with rheumatoid arthritis. Proc. Staff Meet. Mayo Clin. 25, 476-478 (1950).
3. Barnes, P. J. & Adcock, I. M. Glucocorticoid resistance in inflammatory diseases. Lancet 373, 1905-1917 (2009).
4. Galon, J. et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16, 61-71 (2002). (Pubitemid 34027951)
5. Stahn, C. & Buttgereit, F. Genomic and nongenomic effects of glucocorticoids. Nat. Clin. Pract. Rheumatol. 4, 525-533 (2008).
6. McMaster, A. & Ray, D. W. Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nat. Clin. Pract. Endocrinol. Metab. 4, 91-101 (2008). (Pubitemid 351156903)
7. Lowenberg, M., Stahn, C., Hommes, D. W. & Buttgereit, F. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 73, 1025-1029 (2008).
8. Clark, A. R. Anti-inflammatory functions of glucocorticoid-induced genes. Mol. Cell Endocrinol. 275, 79-97 (2007). (Pubitemid 47259278)
9. Mittelstadt, P. R. & Ashwell, J. D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276, 29603-29610 (2001).
10. Ayroldi, E. et al. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol. Cell Biol. 22, 7929-7941 (2002). (Pubitemid 35217302)
11. Ayroldi, E. et al. GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J. Clin. Invest. 117, 1605-1615 (2007). (Pubitemid 46871345)
12. Ayroldi, E. et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor êB. Blood 98, 743-753 (2001).
13. Ayroldi, E. & Riccardi, C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23, 3649-3658 (2009).
14. Riccardi, C., Bruscoli, S., Ayroldi, E., Agostini, M. & Migliorati, G. GILZ, a glucocorticoid hormone induced gene, modulates T lymphocytes activation and death through interaction with NF-êB. Adv. Exp. Med. Biol. 495, 31-39 (2001). (Pubitemid 34106914)
15. D'Adamio, F. et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7, 803-812 (1997). (Pubitemid 28064893)
16. Simmonds, R. E. & Foxwell, B. M. Signalling, inflammation and arthritis. Rheumatology 47, 584-590 (2008).
17. De Bosscher, K., Vanden Berghe, W. & Haegeman, G. The interplay between the glucocorticoid receptor and nuclear factor-êB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24, 488-522 (2003). (Pubitemid 37059110)
18. Eddleston, J., Herschbach, J., Wagelie-Steffen, A. L., Christiansen, S. C. & Zuraw, B. L. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J. Allergy Clin. Immunol. 119, 115-122 (2007). (Pubitemid 46037795)
19. Yang, Y. H., Aeberli, D., Dacumos, A., Xue, J. R. & Morand, E. F. Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper. J. Immunol. 183, 1435-1445 (2009).
20. Yang, N., Zhang, W. & Shi, X. M. Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J. Cell Biochem. 103, 1760-1771 (2008). (Pubitemid 351501908)
21. Berrebi, D. et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101, 729-738 (2003). (Pubitemid 36077600)
22. Delfino, D. V., Agostini, M., Spinicelli, S., Vacca, C. & Riccardi, C. Inhibited cell death, NF-êB activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ. Int. Immunopharmacol. 6, 1126-1134 (2006). (Pubitemid 43728169)
23. Shiozawa, S. & Tsumiyama, K. Pathogenesis of rheumatoid arthritis and c-Fos/AP-1. Cell Cycle 8, 1539-1543 (2009).
24. Wagner, E. F. Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann. Rheum. Dis. 69 (Suppl. 1), i86-i88 (2010).
25. Ralph, J. A. & Morand, E. F. MAPK phosphatases as novel targets for rheumatoid arthritis. Expert Opin. Ther. Targets. 12, 795-808 (2008). (Pubitemid 352003321)
26. Yang, Y. H. et al. Annexin 1 negatively regulates IL-6 expression via effects on p38 MAPK and MAPK phosphatase-1. J. Immunol. 177, 8148-8153 (2006). (Pubitemid 44846334)
27. Bladh, L. G., Johansson-Haque, K., Rafter, I., Nilsson, S. & Okret, S. Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)- êB activity by glucocorticoids. Biochim. Biophys. Acta 1793, 439-446 (2009).
28. Reedquist, K. A., Ludikhuize, J. & Tak, P. P. Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis. Biochem. Soc. Trans. 34, 727-730 (2006). (Pubitemid 44796406)
29. Schmidt, M. et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin, D. Mol. Cell Biol. 22, 7842-7852 (2002). (Pubitemid 35217295)
30. KIP1. Mol. Cell Biol. 20, 9138-9148 (2000). (Pubitemid 32246103)
31. kip1. Nature 404, 782-787 (2000). (Pubitemid 30212408)
32. Asselin-Labat, M. L. et al. GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 104, 215-223 (2004).
33. Asselin-Labat, M. L. et al. FoxO3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression. Mol. Endocrinol. 19, 1752-1764 (2005).
34. Latré De Laté, P. et al. Glucocorticoid-induced leucine zipper (GILZ) promotes the nuclear exclusion of FOXO3 in a Crm1-dependent manner. J. Biol. Chem. 285, 5594-5605 (2010).
35. Hamdi, H. et al. Glucocorticoid-induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis. Hepatology 46, 1986-1992 (2007).
36. Godot, V. et al. Dexamethasone and IL-10 stimulate glucocorticoid-induced leucine zipper synthesis by human mast cells. Allergy 61, 886-890 (2006). (Pubitemid 43893992)
37. Cohen, N. et al. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107, 2037-2044 (2006). (Pubitemid 43289388)
38. Baschant, U. & Tuckermann, J. The role of the glucocorticoid receptor in inflammation and immunity. J. Steroid Biochem. Mol. Biol. 120, 69-75 (2010).
39. Hamdi, H. et al. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 110, 211-219 (2007). (Pubitemid 47026837)
40. H2 and tolerogenic responses. Nat. Immunol. 11, 647-655 (2010).
41. Dudhgaonkar, S. P., Janardhanam, S. B., Kodumudi, K. N. & Srinivasan, M. CD80 blockade enhance glucocorticoid-induced leucine zipper expression and suppress experimental autoimmune encephalomyelitis. J. Immunol. 183, 7505-7513 (2009).
42. Delfino, D. V., Agostini, M., Spinicelli, S., Vito, P. & Riccardi, C. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 104, 4134-4141 (2004). (Pubitemid 39620166)
43. Herold, M. J., McPherson, K. G. & Reichardt, H. M. Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 63, 60-72 (2006). (Pubitemid 43100281)
44. Cannarile, L. et al. Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines. Blood 107, 1039-1047 (2006). (Pubitemid 43156303)
45. Cannarile, L. et al. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 136, 530-541 (2009).
46. Beaulieu, E. et al. Glucocorticoid-induced leucine zipper is an endogenous anti-inflammatory mediator in arthritis. Arthritis Rheum. 62, 2651-2661 (2010).
47. van Der Laan, S. et al. Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain. J. Neurochem. 106, 2515-2523 (2008).
48. Wang, Y. et al. Enhanced resistance of restraint-stressed mice to sepsis. J. Immunol. 181, 3441-3448 (2008).
49. Lekva, T. et al. The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis. J. Clin. Endocrinol. Metab. 95, 246-255 (2010).
50. Redjimi, N. et al. Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer. Mol. Cancer 8, 83 (2009).
51. Zacharchuk, C. M., Mercep, M., Chakraborti, P. K., Simons, S. S. Jr & Ashwell, J. D. Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. J. Immunol. 145, 4037-4045 (1990).
52. Ploner, C. et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J. Steroid Biochem. Mol. Biol. 93, 153-160 (2005). (Pubitemid 40602487)
53. Smit, P. et al. Differential regulation of synthetic glucocorticoids on gene expression levels of glucocorticoid-induced leucine zipper and interleukin-2. J. Clin. Endocrinol. Metab. 90, 2994-3000 (2005). (Pubitemid 40686355)
54. Donn, R. et al. Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J. 21, 402-414 (2007). (Pubitemid 46213488)
55. Spreafico, A. et al. Role of apoptosis in osteoporosis induced by glucocorticoids. J. Endocrinol. Invest. 31, 22-27 (2008).
56. Shi, X. et al. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 4, 374-380 (2003). (Pubitemid 36622002)
57. Zhang, W., Yang, N. & Shi, X. M. Regulation of MSC osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J. Biol. Chem. 283, 4723-4729 (2008).
58. Bruscoli, S. et al. Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids. J. Biol. Chem. 285, 10385-10396 (2010).
59. +. J. Am. Soc. Nephrol 14, 1107-1115 (2003). (Pubitemid 36514653)
60. Fernandes-Rosa, F. L. et al. Mineralocorticoid receptor mutations differentially affect individual gene expression profiles in pseudohypoaldosteronism type 1. J. Clin. Endocrinol. Metab. 96, E519-E527 (2011).
61. Di Marco, B. et al. Glucocorticoid-induced leucine zipper (GILZ)/NF-êB interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res 35, 517-528 (2007). (Pubitemid 46232068)
62. Ehrchen, J. et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109, 1265-1274 (2007). (Pubitemid 46220679)
63. Bhalla, V., Soundararajan, R., Pao, A. C., Li, H. & Pearce, D. Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ. Am. J. Physiol. Renal Physiol. 291, F714-F721 (2006). (Pubitemid 44506967)
64. Soundararajan, R., Zhang, T. T., Wang, J., Vandewalle, A. & Pearce, D. A novel role for glucocorticoid-induced leucine zipper protein in epithelial sodium channel-mediated sodium transport. J. Biol. Chem. 280, 39970-39981 (2005). (Pubitemid 41779132)
65. Chivers, J. E. et al. Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids. Mol. Pharmacol. 70, 2084-2095 (2006). (Pubitemid 44771924)
66. Wang, J. C. et al. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc. Natl Acad. Sci. USA 101, 15603-15608 (2004).
67. Soundararajan, R., Wang, J., Melters, D. & Pearce, D. Differential activities of glucocorticoid-induced leucine zipper protein isoforms. J. Biol. Chem. 282, 36303-36313 (2007).